Evaluation of potential drug interactions of oral anticoagulants in athletic patients based on pharmacy information databases

• Jun Xu ^[1] ; Jinjin Yin ^[1] ; ZhengRong Mei ^[1] ; Ying Wang ^[1] ; Shaozhi Liu ^[1]
  1. [1] Medical University, Guangzhou
• Localización: Revista Internacional de Medicina y Ciencias de la Actividad Física y del Deporte, ISSN-e 1577-0354, Vol. 23, Nº. 90, 2023, págs. 135-146
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • The interactions between hypoglycemic drugs and other drugs were retrieved based on the pharmacy information database to evaluate the X-level/contraindication and D-level/serious potential drug interactions (pDDIs) of outpatient anticoagulant prescriptions, so as to provide a guarantee for clinically safe drug use. METHODS: Based on the interaction of 5 oral anticoagulants recommended in the "China Guidelines for the Prevention and Treatment of Thrombotic Diseases (2018 Edition)" retrieved from the two databases of Lexicomp and Micromedex, statistics of a hospital from January 1,2021 to 2022 During March 31st,200 outpatients with anticoagulant prescriptions for grade X/contraindication and grade D/severe pDDIs were analyzed by multivariate Logistic binary regression analysis. RESULTS: Among the 200 athletic patients, there were 0 pairs of grade X/taboo pDDIs,and 67 pairs of grade D/severe pDDIs, mainly due to grade D/serious potential bleeding caused by the combination of anticoagulants and non-steroidal anti-inflammatory drugs(NSAIDs) risk. Multivariate Logistic binary regression analysis found that multiple drug combination (≥5 kinds) and concomitant cardiovascular disease were risk factors for the occurrence of grade D/severe pDDIs. CONCLUSION: for athletic patients with multiple diseases coexisting and needing to take multiple drugs, it is necessary to pay attention to the pDDIs of anticoagulant drugs, select appropriate drugs, and avoid fatal risks such as severe bleeding. Adverse reactions after medication were closely monitored.

• Referencias bibliográficas
  • Antman, E. M., Bennett, J. S., Daugherty, A., Furberg, C., Roberts, H., & Taubert, K. A. (2007). Use of nonsteroidal antiinflammatory...
  • Armbruster, A. L., Buehler, K. S., Min, S. H., Riley, M., & Daly, M. W. (2014). Evaluation of dabigatran for appropriateness of use and...
  • da Costa, B. R., Reichenbach, S., Keller, N., Nartey, L., Wandel, S., Jüni, P., & Trelle, S. (2016). Retracted: effectiveness of...
  • Food, & Administration, D. Drug safety communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory...
  • FRICKE, R. (2020). New record of the Oriental armoured gurnard Scalicus orientalis (Fowler 1938) from La Réunion, southwestern Indian Ocean...
  • Gray, S. L., Hart, L. A., Perera, S., Semla, T. P., Schmader, K. E., & Hanlon, J. T. (2018). Meta‐analysis of interventions to reduce...
  • Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Hendriks, J. (2016). 2016 ESC Guidelines for the management...
  • Lam, J., Gomes, T., Juurlink, D. N., Mamdani, M. M., Pullenayegum, E. M., Kearon, C., . . . Holbrook, A. M. (2013). Hospitalization for hemorrhage...
  • Lanas, A., Benito, P., Alonso, J., Hernández-Cruz, B., Barón-Esquivias, G., Perez-Aísa, Á., . . . Gonzalez-Juanatey, J. R. (2014)....
  • Lanas, Á., Carrera-Lasfuentes, P., Arguedas, Y., García, S., Bujanda, L., Calvet, X., . . . Muñoz, M. (2015). Risk of upper and...
  • Lee, S.-R., Choi, E.-K., Kwon, S., Han, K.-D., Jung, J.-H., Cha, M.-J., . . . Lip, G. Y. (2019). Effectiveness and safety of contemporary...
  • López-López, J. A., Sterne, J. A., Thom, H. H., Higgins, J. P., Hingorani, A. D., Okoli, G. N., . . . Welton, N. J. (2017). Oral anticoagulants...
  • Masclee, G. M., Valkhoff, V. E., Coloma, P. M., de Ridder, M., Romio, S., Schuemie, M. J., . . . Picelli, G. (2014). Risk of...
  • McDonald, E. G., Wu, P. E., Rashidi, B., Wilson, M. G., Bortolussi-Courval, É., Atique, A., . . . Wilson, A. G. (2022). The MedSafer study—electronic...
  • McGettigan, P., & Henry, D. (2006). Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational...
  • McInnes, G., Lawson, D., & Jick, H. (1981). Acute adverse reactions attributed to allopurinol in hospitalised patients. Annals of the...
  • Obeid, S., Libby, P., Husni, E., Wang, Q., Wisniewski, L. M., Davey, D. A., . . . Walker, C. (2022). Cardiorenal risk of celecoxib compared...
  • Olsen, A.-M. S., Gislason, G. H., McGettigan, P., Fosbøl, E., Sørensen, R., Hansen, M. L., . . . Lamberts, M. (2015). Association of NSAID...
  • Radaelli, F., Dentali, F., Repici, A., Amato, A., Paggi, S., Rondonotti, E., & Dumonceau, J. M. (2015). Management of anticoagulation...
  • Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., . . . Parkhomenko, A. (2014). Comparison...
  • Valkhoff, V. E., van Soest, E. M., Sturkenboom, M., & Kuipers, E. J. (2010). Time‐trends in gastroprotection with nonsteroidal anti‐inflammatory...
  • Vargas, C. R., Deon, M., Sitta, A., Coelho, D. M., Silva, P. D., Murussi, L., . . . Sanseverino, M. T. V. (2020). The value of fasting in...